Skip to main content
Journal of Pharmacy & Bioallied Sciences logoLink to Journal of Pharmacy & Bioallied Sciences
. 2025 Dec 29;18(Suppl 1):S51–S53. doi: 10.4103/jpbs.jpbs_1541_25

Influence of Gingival Phenotype on Crestal Bone Loss at Implants

Mohd Azeem 1, Sneha Patel 2, Rishabh Ranjan 2, Meenal Verma 3, Gutta Veda Sri 4, Rakesh Nagaraju 5, Charumati Dhanushkodi 6, Nandita Gautam 7,
PMCID: PMC12995153  PMID: 41853002

Abstract

Aim:

Crestal reduction at implants occurs within the first year of pressure due beginning physiologic remodelling phase following surgical trauma and function loading of the crestal bone.

Materials and Methods:

Ninety-seven individuals were assessed for 4.1 mm bone-level implantation. Participants were separated onto three categories according to how much vertically gingival width: test T1, test T2, along with control C. A radiographic analysis was done afterwards implant placement, two months afterwards recovery, prostheses repair, and a follow-up appointment for one year. The Mann-Whitney U-test was employed, with a threshold of significance of 0.05.

Results:

While the variations among T2 and C hadn’t been relevant either mesially (P = 0.861) or distal (P = 0.827), the variations were substantial (P = 0.000) comparing T1/T2 and T1/C.

Conclusion:

The breakdown of bones may be significantly lowered when osteo-level prostheses are put in inherently dense tissue rather than thinner biotypes.

KEYWORDS: Crestal bone, Gingival phenotype, Dental Implant

INTRODUCTION

The 2017 World Workshop on the Classification of Periodontal and Peri-Implant Disease and Conditions has recommended adoption of the term “periodontal phenotype” by the periodontal community.[1] Crestal reduction at implants occurs within the first year of pressure due beginning physiologic remodelling phase following surgical trauma and function loading of the crestal bone. Despite with good implants, yearly bone loss (≤0.2 mm) can happen over time. Peri-implant bone loss is caused by microbially linked, host-mediated inflammation and non-inflammatory variables like as osseous diseases, improperly controlled diabetes, titanium flake launch, and occlusion overload.[2]

Purpose of this long-term cohort investigation in periodontally impaired individuals who have implants is to investigate the relationship among gum phenotype and peri-implant crestal loss of bone.

MATERIALS AND METHOD

Study was carried out at Department of Prosthodontics and Crown and Bridge, Santosh Dental College Ghaziabad. Criteria for inclusion included no <15%, PI <15%, CPITN <2, atleast 2 mm keratinised gum on buccal and lingual side, not having bone placement surgeries prior to and after implantation, and a written informed agreement with authorisation to utilise data for investigation. Patients terminated if not match the eligibility and also with lack of mouth cleanliness. H/O untreated periodontitis; smoking; DM; drinking; medication use, impacting repair. Around, 97 subjects, composed of 28 males and 69 females, obtained a 2 g dosage of amoxil as a preventative measure.

1 hour before surgery. Following administering 4% articaine, a mid-crestal incision in the centre of the toothless ridges was made. Following crestal incision, the buccal flap had been raised, but the lingual portion was not lifted to ensure direct visibility. Longitudinal tissue thicknesses was assessed using a 1.0 mm indicated periodontal probed at the bone crest in the middle of the prospective implanted site. Following measuring, the lingual flap was lifted to reveal entirely the implant implantation site. Tiny tissue were defined as those with a vertically layer thickness of 2 mm or lower. The tissue thicknesses surpassing two millimetres was considered heavy.

As a result, three categories created: T1 testing cohort—implant inserted into thin fibres; T2 test team—implantation inserted in tissue that was thin and thickened allogenic membrane concurrently implant location; C, the control population—dental implants inserted natively dense tissues. Following full-thickness flaps height, the covering was fastened above the implants immediately on the bone surface, and the tissues were sutured with 4/0 sutures. Individuals were directed to clean operating sites with 0.12% chlorhexidine solutions twice per day for an entire week and to take 0.5 g amoxicillin three times a day for the next seven days. For pain relief, participants warned to administer 400 mg of ibuprofen as recommended. Participants were instructed to avoid trauma to the location and to treat healed attachments with gentle toothbrush. Stitches taken out 7 to 10 days following surgeries. Following two months of recovery, metallic restorations made of ceramic had been set with resin-based adhesive on conventional abutments in laboratory setting. Replacements were secured with screws onto implants, and screw access was irreversibly sealed via light-cured composite. Intraoral images were taken on four occasions in every participant throughout course of research: (i) following implant insertion, (ii) following two months of regeneration, (iii) following prosthesis transportation, and (iv) afterwards one year of reconstruction.

RESULTS

The ultimate study sample contained 97 bone-level implantation with substrate switching. T1 obtained 33 implants, T2 received 32 devices, and control category C was given 32 implantation. All 97 prostheses been effectively consolidated and regenerated with 97 metal-ceramic restorations held together by cement screws. Ultimately, both test and control groupings had 100% implant longevity following year of operation. No prosthesis problems have been found during subsequent appointments. All 97 allogenic membranes resolved normally, with no exposes or infection seen.

Statistical difference in all groups between period of 2 months after placement and 1- year follow-up (Mann–Whitney U-test, significant when P ≤ 0.05) was done and found group T1-mesially with mean —1.22, median of —1.20 and distally presented mean —1.14 and median of —1.14. In group T2-mesially with mean —0.24, median of ——0.06 and distally presented mean —0.19 and median of ——0.06. In group C-mesially with mean of —0.22, median of —0.06 and distally presented mean —0.19 and median of ——0.06. T1 and T2- P value mesially and distally was 0.000 respectively. Among T2 and C presented P value of 0.909 mesially and 0.312 distally. Also, T1 and C P value mesially and distally was 0.000, respectively [Table 1].

Table 1.

The statistical evaluation of crestal reduction in bone surrounding implants following prosthesis replacement. (Mann–Whitney U-test)

Group Group Mean SE Median Maximum Minimum
T1 (n=33) Mesially —1.00 0.15 —0.85 0.30 —3.70
Distally —0.93 0.11 —0.80 0.00 —3.10
T2 (n=32) Mesially —0.25 0.06 —0.05 0.00 —1.00
Distally —0.24 0.06 0.00 0.10 —1.10
C (n=32) Mesially —0.22 0.06 0.00 0.00 —1.10
Distally —0.19 0.06 —0.05 0.00 —1.00

Group Mesially Distally

T1 and T2 P=0.000 P=0.000
T2 and C P=0.734 P=0.987
T1 and C P=0.000 P=0.000

DISCUSSION

The findings of present investigation revealed that dental implants in grouping T2 via thin tissue layers that were grew with allogenic barrier experienced substantially fewer crestal reduction in bone through every measure than surgical implants in category T1, where fragile tissues did not get thicker, and thus assumption of nullity needs to dismissed. It represents preliminary clinical investigation to look at effect of vertically cell thickness allogenic membranes on crestal bone durability. Findings demonstrate that early mucosal tissue thickness may play significant role in aetiology of crestal reduction in bone.

It is worth noting that among thinner soft tissue samples, loss of bone was evident at time of first measurement—two months following implant implantation. The measuring time had been selected based on experimental findings.[3] A primary underdeveloped peri-implant tissue seal forms within week of single-stage implantation attachment of healed abutment in a two-phase operation. Latest research investigation shows that initial radiographic evidence for biologic wide creation on bone slabs appear approximately two months following regeneration, prior to implant loads.[4]

The loss of bone prior loads is typically linked to inadequate surgery,[5] or inadequate dental hygiene. Nevertheless, fresh information demonstrates that bone loss prior to loads may be the result of biological thickness development if implants are positioned in thin soft tissue layers. Each the cohort experienced increased bone loss between 2 months and 1 year of follow-up. The following could be attributed to the fact that restoration operations were being performed, which included several healed abutment disruptions.

CONCLUSION

Considering constraints of present investigation, it’s possible to determine that width of mucosal tissue is 2 mm or fewer, considerable crestal reduction in bone may occur. When structures vertically strengthened by allogenic membranes throughout 1-stage an operation, crestal bone integrity is significantly improved.

Conflicts of interest

There are no conflicts of interest.

Funding Statement

Nil.

REFERENCES

  • 1.Jepsen S, Caton JG, Albandar JM, Bissada NF, Bouchard P, Cortellini P, et al. Periodontal manifestations of systemic diseases and developmental and acquired conditions: consensus report of workgroup 3 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol. 2018;89(Suppl 1):S237–48. doi: 10.1002/JPER.17-0733. [DOI] [PubMed] [Google Scholar]
  • 2.Schwarz F, Derks J, Monje A, Wang HL. Peri-implantitis. J Clin Periodontol. 2018;45(Suppl 20):246–66. doi: 10.1111/jcpe.12954. [DOI] [PubMed] [Google Scholar]
  • 3.Berglundh T, Abrahamsson I, Welander M, Lang NP, Lindhe J. Morphogenesis of the peri-implant mucosa: An experimental study in dogs. Clin Oral Implants Res. 2007;18:1–8. doi: 10.1111/j.1600-0501.2006.01380.x. [DOI] [PubMed] [Google Scholar]
  • 4.Toljanic JA, Banakis ML, Willes LA, Graham L. Soft tissue exposure of endosseous implants between stage I and stage II surgery as a potential indicator of early crestal bone loss. Int J Oral Maxillofac Implants. 1999;14:43–41. [PubMed] [Google Scholar]
  • 5.Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. (II). Etiopathogenesis. Eur J Oral Sci. 1998;106:721–64. doi: 10.1046/j.0909-8836..t01-6-.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Pharmacy & Bioallied Sciences are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES